Technology | Quality Assurance (QA) | September 12, 2019

IBA Dosimetry Releases myQA Machines Software at ASTRO 2019

New release of myQA Machines enables more efficient radiation therapy machine quality assurance, integrated into the independent global QA platform myQA

IBA Dosimetry Releases myQA Machines Software at ASTRO 2019

September 12, 2019 – IBA Dosimetry GmbH announced the launch of the new enhanced myQA Machines 2019 software environment at the upcoming American Society for Radiation Oncology (ASTRO) congress, Sept. 15-19 in Chicago.

The latest version of the myQA Machines software enables significantly faster execution of all key linear accelerator (linac) quality assurance (QA) tests. It also allows machine QA tests to be performed independently of the linac systems that are being verified.

The new myQA Machines has been designed to ensure QA efficiency through close integration with the treatment machines while maintaining independence from the machines to be tested, to provide the most reliable quality assurance performance.

To enhance workflow efficiency, each of the linac-specific tests of myQA Machines — like the multileaf collimator (MLC) and volumetric modulated arc therapy (VMAT) checks, as well as the 2-D and 3-D imaging QA tests — can now be measured and analyzed easily in a single workflow that is integrated in one dedicated software interface. Test automation further contributes to QA efficiency and avoids human subjectivity during test analysis.

For more information: www.iba-worldwide.com

Related Content

Videos | Radiation Oncology | October 11, 2019
Lorraine Drapek, DNP, nurse practitioner, radiation oncology, GI service,...
Patient Treatments With ViewRay's MRIdian Linac Begin in New England
News | Image Guided Radiation Therapy (IGRT) | October 08, 2019
ViewRay Inc. announced today that patient treatments are scheduled to begin in Boston with ViewRay's MRIdian Linac...
ProTom International received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Radiance 330 proton therapy system
News | Proton Therapy | October 07, 2019
ProTom International received 510(k) clearance from the U.S.
Attendees of ASTRO 2019 walked the halls of McCormick Place in Chicago, Ill.

Attendees of ASTRO 2019 walked the halls of McCormick Place in Chicago, Ill.

Feature | ASTRO | October 03, 2019 | By Greg Freiherr
At the American Society for Radiation Oncology’s (ASTRO) 2019 a
Videos | Prostate Cancer | September 30, 2019
Bill Hartsell, M.D., medical director of the Northwestern Medicine Proton Center in Warrenville, Ill., discusses the
eBook on Hypofractionation in the Age of Value-based Care

eBook on Hypofractionation in the Age of Value-based Care

Sponsored Content | Case Study | Radiation Therapy | September 30, 2019
Hypofractionated and ultrahypofractionated radiation therapy — increasing dose per fraction to enable significantly f
AI Accurately Predicts Radiotherapy Side Effects for Head and Neck Cancer Patients
News | Artificial Intelligence | September 26, 2019
For the first time, a sophisticated computer model has been shown to accurately predict two of the most challenging...